Sandoz Romania company information, Employees & Contact Information

Sandoz and Regeneron reach agreement over biosimilar dispute Ophthalmology Times

Corporate Governance Sandoz

Sandoz, on a $1.1B investment spree in Slovenia, breaks ground at new $440M biosimilar plant Fierce Pharma

Sandoz reaches agreement with Regeneron, resolving all patent litigation related to its US aflibercept biosimilar Sandoz

Sandoz CEO on navigating Trump's tariffs, "distorted" U.S. drug market Axios

Sandoz launches renewable energy partnership to cover nearly 90% of electricity demand for European operations Sandoz

Sandoz bolsters in-house biosimilar manufacturing with Evotec acquisition Pharmaceutical Technology

Sandoz CEO slams EU-wide drug price proposal, warns US tariffs will hurt patient access Reuters

Lincoln Journal Star highlights Sandoz digitization project University of Nebraska–Lincoln

Sandoz further asserts leadership in biosimilars, breaking GlobeNewswire

Sandoz signs non-binding term sheet with Evotec SE to acquire its Just-Evotec Biologics in-house development and manufacturing capabilities in Toulouse, France Sandoz

Sandoz recalls one lot of antibacterial drug cefazolin due to mispackaging Fierce Pharma

Sandoz to pay $275 million to settle drug price-fixing case Reuters

Product Safety Notices Sandoz

Sandoz enters global collaboration license agreement with Henlius to commercialize leading oncology therapy, ipilimumab, in multiple indications Sandoz

Sandoz launches Pyzchiva® autoinjector, first commercially available in Europe for ustekinumab biosimilars Sandoz

Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1] Sandoz

Sandoz opens new Device Development Center in Cambridge, UK Sandoz

Sandoz joins Energize Program to support suppliers in decarbonization efforts Sandoz

Evotec offloads France biosimilars plant to Sandoz for $300M Fierce Pharma

Trump’s tariffs won’t lead to more medicines investment in US, Sandoz boss says politico.eu

Jim Sandoz Obituary (2024) - Baltimore, MD - Baltimore Sun Legacy obituary

Business Sandoz

Sandoz lifts guidance after Humira biosimilar drives another quarter of sales growth Fierce Pharma

About Sandoz Sandoz

With settlement, Sandoz can launch its biosimilar to Regeneron's Eylea by end of 2026 Fierce Pharma

Helen Sandoz Obituary (1933 - 2023) - Portland, OR OregonLive.com

Sandoz Sources Renewable Energy for 90% of Europe Operations ESG Today

Sandoz enters $265 million settlement agreement in U.S. price-fixing case Reuters

Sandoz launches ustekinumab biosimilar in Europe Pharmaceutical Technology

Sandoz takes Amgen to court again, challenging its patents on decades-old Enbrel Fierce Pharma

Sandoz receives US FDA approval for biosimilar Hyrimoz® (adalimumab-adaz) high-concentration formulation Novartis

Novartis' Sandoz dips on debut after lower than expected valuation Reuters

Novartis confirms Sandoz Spin-off for October 4, 2023 Novartis

Select strengths of Sandoz immunology biosimilar granted interchangeability by FDA Sandoz

Novartis announces intention to separate Sandoz business to create a standalone company by way of a 100% spin-off Novartis

Sandoz taps Evotec in long-term biosimilar development and manufacturing deal Fierce Pharma

People and culture Sandoz

Sandoz delivers 6% sales growth with Humira biosimilar leading the charge Fierce Pharma

Sandoz Antibiotic Manufacturing Facility, Kundl, Austria Pharmaceutical Technology

Sandoz signs Science Based Targets Initiative (SBTi) Commitment Letter Sandoz

Sandoz celebrates the inauguration of new global headquarters in Basel Sandoz

Evotec, Sandoz expand biosimilar production pact inked last year Fierce Pharma

Generics Sandoz

Amid tough generics market, Sandoz to lay off 213 and shutter Eon Labs plant in North Carolina Fierce Pharma

Sandoz, Liquidia score $137M win against United in yearslong generic Remodulin dispute Fierce Pharma

In splitting from Novartis, Sandoz makes muted market debut Fierce Pharma

As Sandoz contract winds down, GSK will close antibiotics plant in UK Fierce Pharma

Environment Sandoz

News Archive Sandoz

After setting out on its own, Sandoz inks $265M deal to resolve 'legacy' price-fixing lawsuit Fierce Pharma

Flexible-Hybrid Working at Sandoz Sandoz

South Africa's Aspen expands reach with $100M buy of Sandoz's Chinese business Fierce Pharma

Sandoz Issues Recall of One Lot of Enoxaparin Sandoz

Media Sandoz

Sandoz completes acquisition of GSK’s cephalosporin business, reinforcing leading global position in antibiotics Novartis

Sandoz announces global deal to commercialize proposed biosimilar natalizumab, a key multiple sclerosis medicine Novartis

Ivan Sandoz Obituary (1933 - 2017) - Portland, OR OregonLive.com

Sandoz proposed biosimilar rituximab accepted for review by the FDA Novartis

Case Note: Sandoz v. Amgen Food and Drug Law Institute (FDLI)

Calcium Sandoz — For 90s kids, the happy-puppy bottle scored over health benefits of the pills ThePrint